Omnicell (OMCL) appoints Perry Genova as CTO

Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, effective March 31, 2025.

In this role, Dr. Genova will lead Omnicell’s technology strategy as the Company works to address pressing issues within medication and supply management across all care settings in an effort to help customers move closer to the industry-defined vision of the Autonomous Pharmacy.

Dr. Genova brings more than 25 years of experience in product development, strategic planning, and regulatory compliance, with a track-record of success in delivering innovation, growth, and value in senior leadership roles for companies across the medical device, pharmaceutical, and life sciences industries

“We believe Perry’s entrepreneurial mindset will be pivotal to advancing our multi-year, outcome-centric growth strategy as we strive to deliver clinical and operational outcomes for our customers,” said Nnamdi Njoku, executive vice president and chief operating officer at Omnicell. “His focus on building trust and collaboration among strategic partners and internal and external stakeholders will help to drive forward our purpose to transform medication management across all care settings.”

You May Also Be Interested In

• PB Fintech Limited (POLICYBZ:IN) PT Raised to INR1,640 at UBS
• Henry Schein (HSIC) announces KKR completes strategic investment, appoints Dan Daniel to Board
• Birks Group, Inc. (BGI) announcesn NYSE acceptance of compliance plan